Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1.
Tanaka M, Yamakage H, Muranaka K, Yamada T, Araki R, Ogo A, Matoba Y, Watanabe T, Saito M, Kurita S, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Matsumoto M, Nishimura M, Kusakabe T, Wada H, Hasegawa K, Kotani K, Noda M, Satoh-Asahara N. Tanaka M, et al. Among authors: araki r. Front Endocrinol (Lausanne). 2022 May 3;13:880148. doi: 10.3389/fendo.2022.880148. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35592778 Free PMC article.
Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes.
Tanaka M, Yamakage H, Masuda S, Inoue T, Ohue-Kitano R, Araki R, Matoba Y, Saito M, Nagaoka T, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Nishimura M, Odori S, Wada H, Kotani K, Kusakabe T, Shimatsu A, Hasegawa K, Satoh-Asahara N. Tanaka M, et al. Among authors: araki r. Diabetes Metab. 2019 Jan;45(1):86-89. doi: 10.1016/j.diabet.2017.06.006. Epub 2017 Jul 31. Diabetes Metab. 2019. PMID: 28774784 No abstract available.
Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R, Yamakage H, Kotani K, Wada H, Otani S, Yonezawa K, Ogo A, Okajima T, Adachi M, Araki R, Yoshida K, Saito M, Nagaoka T, Toyonaga T, Tanaka T, Yamada T, Ota I, Oishi M, Miyanaga F, Shimatsu A, Satoh-Asahara N; Japan Diabetes and Obesity Study (J-DOS) Group. Ito R, et al. Among authors: araki r. Endocr J. 2015;62(2):201-7. doi: 10.1507/endocrj.EJ14-0352. Epub 2014 Nov 14. Endocr J. 2015. PMID: 25399862 Free article.
Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS).
Satoh-Asahara N, Kotani K, Yamakage H, Yamada T, Araki R, Okajima T, Adachi M, Oishi M, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Satoh-Asahara N, et al. Among authors: araki r. Atherosclerosis. 2015 Oct;242(2):461-8. doi: 10.1016/j.atherosclerosis.2015.08.003. Epub 2015 Aug 8. Atherosclerosis. 2015. PMID: 26295798
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome.
Kotani K, Satoh N, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Yamakage H, Yamada K, Hattori M, Shimatsu A; Japan Obesity and Metabolic Syndrome Study Group. Kotani K, et al. Among authors: araki r. Atherosclerosis. 2009 Jun;204(2):526-31. doi: 10.1016/j.atherosclerosis.2008.09.017. Epub 2008 Sep 27. Atherosclerosis. 2009. PMID: 19007930
Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia.
Tagami T, Kimura H, Ohtani S, Tanaka T, Tanaka T, Hata S, Saito M, Miyazaki Y, Araki R, Tanaka M, Yonezawa K, Sawamura M, Ise T, Ogo A, Shimbo T, Shimatsu A, Naruse M; PHPH study group. Tagami T, et al. Among authors: araki r. Endocr J. 2011;58(6):449-57. doi: 10.1507/endocrj.k11e-012. Epub 2011 Apr 20. Endocr J. 2011. PMID: 21505266 Free article.
Remnant-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome.
Kotani K, Asahara-Satoh N, Kato Y, Araki R, Himeno A, Yamakage H, Koyama K, Tanabe M, Oishi M, Okajima T, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Kotani K, et al. Among authors: araki r. J Clin Lipidol. 2011 Sep-Oct;5(5):395-400. doi: 10.1016/j.jacl.2011.08.001. Epub 2011 Aug 12. J Clin Lipidol. 2011. PMID: 21981841
Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.
Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Himeno A, Kono S, Sugawara A, Hattori M, Ogawa Y, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Satoh-Asahara N, et al. Among authors: araki r. Clin J Am Soc Nephrol. 2011 Feb;6(2):265-73. doi: 10.2215/CJN.04830610. Epub 2010 Nov 4. Clin J Am Soc Nephrol. 2011. PMID: 21051748 Free PMC article.
381 results